Awarded Grants
Below is a listing of our awarded grants that tackle big food and agriculture challenges.

Refine Results
Challenge Areas & Initiatives
Consortia
Program
    See more
Scientific Workforce Programs
Continent
Location
    See more
Year
    See more
Order

93 Grants found

Hide map

ICASA: Pathogen-host interaction during the development of liver abscesses; local and systemic immune and metabolic responses during Fusobacterium necrophorum challenges

Year Awarded  2022

FFAR award amount   $97,400

Total award amount   $195,140

Location   Lubbock, TX

Matching Funders   Texas Tech University

Grantee Institution   Texas Tech University

Texas Tech University researchers are identifying potential pathways in which the bacteria subvert the hosts’ defenses during the development of liver abscess to lay the foundation for the formation of novel approaches, such as alternative drugs, that can potentially replace antimicrobials in liver abscess control and prevention strategies.

ICASA: Liver abscesses in feedlot cattle; further delineation of the etiology and pathogenesis

Year Awarded  2022

FFAR award amount   $125,000

Total award amount   $280,000

Location   Manhattan, KS

Matching Funders   Cargill Incorporated , Micronutrients Corporation ,and Phibro Animal Health Corporation

Grantee Institution   Kansas State University

Kansas State University researchers are identifying specific bacterial species in cattle liver abscesses beyond the primary species, Fusobacterium necrophorum, and determining their prevalence and involvement in abscess formation, especially in the under-studied hindgut segment of the gastrointestinal tract. This research could help identify new interventions to minimize the occurrence of liver abscesses in cattle.

ICASA: Improving the efficacy of vaccination against mycoplasma hyosynoviae by identifying optimal application times

Year Awarded  2022

FFAR award amount   $149,748

Total award amount   $359,618

Location   St. Paul, MN

Matching Funders   Boehringer Ingelheim, Newport Laboratories, Pipestone Veterinary Services, Tyson Foods and University of Minnesota

Grantee Institution   University of Minnesota, College of Veterinary Medicine

University of Minnesota researchers are identifying the optimal time for vaccine application against M. hyosynoviae, which will result in significant prevention of lameness development in grow-finish swine and translate into reduced use of antibiotics for disease control.

ICASA: Risk Factors for Lameness in Finishing Pigs

Year Awarded  2022

FFAR award amount   $127,703

Total award amount   $268,493

Location   Philadelphia, PA

Matching Funders   PIC and University of Pennsylvania

Grantee Institution   University of Pennsylvania , School of Veterinary Medicine

University of Pennsylvania researchers are identifying factors that cause swine lameness to determine whether management factors like floor type, pen size and nutrition underlie common lameness problems. Little is known about the incidence and causes of lameness in swine.

ICASA: Development of a non-invasive model to induce liver abscess formation in cattle

Year Awarded  2022

FFAR award amount   $85,700

Total award amount   $180,922

Location   Beltsville, MD

Matching Funders   USDA-ARS, Kansas State University and West Texas A&M University

Grantee Institution   U.S. Department of Agriculture’s Agricultural Research Service

USDA-ARS researchers are developing a minimally invasive model that induces liver abscesses and improves researchers’ ability to study the development and mitigation of the abscesses, while reducing the time necessary to generate enough animals to study.

Building a Common Language for Antimicrobial Resistance Between Human & Animal Health

Year Awarded  2022

FFAR award amount   $216,724

Total award amount   $433,449

Location   Ames, IA

Program   Seeding Solutions

Matching Funders   Merck MSD

To strengthen antimicrobial stewardship within livestock veterinary medicine this research aims to develop a standard method of collecting, reporting and sharing multispecies antimicrobial susceptibility testing (AST) results for use in human and animal health industries.

Investigating Natural Nitro-Compounds as a Viable Strategy to Reduce Enteric Methane Emission from Ruminants

Year Awarded  2022

FFAR award amount   $455,704

Total award amount   $914,543

Location   State College, PA

Program   Seeding Solutions

Matching Funders   Purina Animal Nutrition

Enteric methane is the single largest source of direct greenhouse gas (GHG) emissions in the beef and dairy sectors, representing 2.5% of total U.S. GHG emissions. Led by Dr. Alexander N. Hristov, researchers are investigating using a non-synthetic form of an anti-methanogenic compound, 3-nitro-1-propionic acid (3-NPA), derived from plant and fungal sources as a feed additive to reduce enteric methane in ruminants.

Fecal Microbiota Transplant to Reduce Post Weaning Diarrhea & Antibiotic Use

Year Awarded  2021

Total award amount   $311,354

Location   Lafayette, IN

Matching Funders   Purdue University and National Pork Board

This research is investigating using fecal microbiota, or stool, transplants to reduce post-weaning diarrhea and antibiotic use in swine. Post-weaning diarrhea is caused when bacteria invade the gut, which becomes weakened from the diet change, transportation and change in environment that occurs during weaning. Researchers are administering the fecal transplants though a feed amendment with freeze-dried fecal microbiota, a less labor-intensive method than traditional oral gavage and better suited for commercial settings. If effective, the results could be optimized for other animal species and be developed into proprietary feed additive-type technologies by the animal health industry.

Improving the Efficacy of Vaccination Against Mycoplasma Hyosynoviae by Identifying Optimal Application Times

Year Awarded  2021

Total award amount   $359,618

Location   St. Paul, MN

Matching Funders   Newport Laboratories, Tyson Foods, Pipestone Veterinary Services, Regents of the University of Minnesota and Boehringer Ingelheim

Mycoplasma hyosynoviae (M. hyosynoviae) bacteria cause respiratory disease and lameness in pigs, contributing to economic loss and decreased animal welfare, and is a major driver of antibiotic use in swine production. This research identifies the optimal time for vaccine application against M. hyosynoviae in swine, which will result in significant prevention of lameness development in grow-finish swine and translate into reduced use of antibiotics for disease control.

Risk Factors for Lameness in Finishing Pigs

Year Awarded  2021

Total award amount   $268,493

Location   Philadelphia, PA

Matching Funders   University of Pennsylvania and PIC

Mycoplasma hyosynoviae (M. hyosynoviae) bacteria cause respiratory disease and lameness in pigs, contributing to economic loss and decreased animal welfare, and is a major driver of antibiotic use in swine production. Little is known about the incidence and causes of lameness in swine. This research is identifying factors that cause swine lameness to determine whether management factors like floor type, pen size and nutrition underlie common lameness problems. If lameness is caused by non-bacterial factors like M. hyosynoviae, alternative methods of prevention can be identified, reducing antibiotic usage.